Sustained complete response to cytotoxic therapy and the PARP inhibitor veliparib in metastatic castration resistant prostate cancer – a case report

by David J VanderWeele, Gladell P Paner, Gini F Fleming, Russell Z Szmulewitz
Published 2015-07-01

Past, Current, and Future of Immunotherapies for Prostate Cancer

by Adeline N. Boettcher, Ahmed Usman, Alicia Morgans, David J. VanderWeele, Jeffrey Sosman, Jennifer D. Wu, Jennifer D. Wu
Published 2019-09-01

A case report of multiple primary prostate tumors with differential drug sensitivity

by Scott Wilkinson, Stephanie A. Harmon, Nicholas T. Terrigino, Fatima Karzai, Peter A. Pinto, Ravi A. Madan, David J. VanderWeele, Ross Lake, Rayann Atway, John R. Bright, Nicole V. Carrabba, Shana Y. Trostel, Rosina T. Lis, Guinevere Chun, James L. Gulley, Maria J. Merino, Peter L. Choyke, Huihui Ye, William L. Dahut, Baris Turkbey, Adam G. Sowalsky
Published 2020-02-01